Breaking News Instant updates and real-time market news.

STRO

Sutro Biopharma

$18.50 /

-0.81 (-4.19%)

07:10
05/07/21
05/07
07:10
05/07/21
07:10

Sutro Biopharma reports Q1 EPS (66c), consensus (60c)

Reports Q1 revenue $14.7M, consensus $5.73M. As of March 31, Sutro had cash, cash equivalents and marketable securities of $294.9M vs. $326.5M as of December 31, 2020, with projected runway into the second half of 2023. "We are enthusiastic about the meaningful clinical benefit of STRO-002, our FolRalpha-targeting Antibody-Drug Conjugate (ADC), for women with advanced ovarian cancer, as demonstrated by the Phase 1 dose-escalation data, and look forward to providing follow-up data at ASCO," said Bill Newell, Sutro's Chief Executive Officer. "We continue to enroll patients for the dose-expansion portion of the Phase 1 study and we have activated additional clinical sites. STRO-002 is one of the four product candidates in the clinic that were discovered, developed, and are manufactured using our proprietary and integrated cell-free protein synthesis platform. We intend to continue creating value by leveraging our platform to deliver on therapeutics that are precise, rationally designed, and homogenous, for a broad set of patients with unmet medical needs."

  • 03

    Jun

  • 12

    May

  • 09

    Dec

STRO Sutro Biopharma
$18.50 /

-0.81 (-4.19%)

01/28/21 Truist
Sutro Biopharma price target raised to $37 from $24 at Truist
12/02/20 Stifel
Sutro Biopharma initiated with a Buy at Stifel
11/06/20 Piper Sandler
Sutro Biopharma price target raised to $22 from $20 at Piper Sandler
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology

TODAY'S FREE FLY STORIES

Earnings
Zillow Group reports Q2 adjusted EBITDA $183M vs. $15.84M last year » 16:21
08/05/21
08/05
16:21
08/05/21
16:21
ZG

Zillow Group

$110.30 /

-0.22 (-0.20%)

, Z

Zillow

$110.28 /

+0.98 (+0.90%)

Reports Q2 revenue $1.3B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZG Zillow Group
$110.30 /

-0.22 (-0.20%)

Z Zillow
$110.28 /

+0.98 (+0.90%)

ZG Zillow Group
$110.30 /

-0.22 (-0.20%)

07/21/21
Fly Intel: Top five analyst initiations
07/21/21 Berenberg
Zillow Group initiated with a Buy at Berenberg
07/08/21 BTIG
Zillow Group price target lowered to $185 from $202 at BTIG
05/26/21 RBC Capital
Zillow Group assumed with an Outperform at RBC Capital
Z Zillow
$110.28 /

+0.98 (+0.90%)

07/21/21 Berenberg
Zillow Group initiated with a Buy at Berenberg
05/26/21 RBC Capital
Zillow Group assumed with an Outperform at RBC Capital
05/07/21 Citi
Zillow Group price target lowered to $230 from $250 at Citi
05/05/21 Evercore ISI
Zillow Group still among top large cap long ideas, says Evercore ISI
ZG Zillow Group
$110.30 /

-0.22 (-0.20%)

Z Zillow
$110.28 /

+0.98 (+0.90%)

ZG Zillow Group
$110.30 /

-0.22 (-0.20%)

Z Zillow
$110.28 /

+0.98 (+0.90%)

ZG Zillow Group
$110.30 /

-0.22 (-0.20%)

Z Zillow
$110.28 /

+0.98 (+0.90%)

Z Zillow
$110.28 /

+0.98 (+0.90%)

Earnings
Vaxart reports Q2 EPS (13c), consensus (14c) » 16:21
08/05/21
08/05
16:21
08/05/21
16:21
VXRT

Vaxart

$8.67 /

+0.39 (+4.71%)

Reports Q2 revenue $112K,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VXRT Vaxart
$8.67 /

+0.39 (+4.71%)

VXRT Vaxart
$8.67 /

+0.39 (+4.71%)

08/02/21 Piper Sandler
Piper 'pleased' to see Vaxart's IND clearance for S-only COVID vaccine candidate
06/30/21
Fly Intel: Top five analyst downgrades
06/30/21 B. Riley
B. Riley downgraded Vaxart to Neutral on 'riskier development path'
06/29/21 B. Riley
Vaxart downgraded to Neutral from Buy at B. Riley
VXRT Vaxart
$8.67 /

+0.39 (+4.71%)

VXRT Vaxart
$8.67 /

+0.39 (+4.71%)

VXRT Vaxart
$8.67 /

+0.39 (+4.71%)

VXRT Vaxart
$8.67 /

+0.39 (+4.71%)

Earnings
Velocity Financial reports Q2 core EPS 25c, consensus 17c » 16:21
08/05/21
08/05
16:21
08/05/21
16:21
VEL

Velocity Financial

$12.25 /

+0.32 (+2.68%)

"Our results this…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VEL Velocity Financial
$12.25 /

+0.32 (+2.68%)

VEL Velocity Financial
$12.25 /

+0.32 (+2.68%)

02/22/21 Citi
Velocity Financial price target raised to $10 from $7 at Citi
08/13/20 JMP Securities
Velocity Financial price target lowered to $7 from $12 at JMP Securities
VEL Velocity Financial
$12.25 /

+0.32 (+2.68%)

VEL Velocity Financial
$12.25 /

+0.32 (+2.68%)

VEL Velocity Financial
$12.25 /

+0.32 (+2.68%)

Earnings
Sierra Oncology reports Q EPS ($1.67), consensus ($1.61) » 16:21
08/05/21
08/05
16:21
08/05/21
16:21
SRRA

Sierra Oncology

$17.24 /

+0.24 (+1.41%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRRA Sierra Oncology
$17.24 /

+0.24 (+1.41%)

SRRA Sierra Oncology
$17.24 /

+0.24 (+1.41%)

12/11/20 H.C. Wainwright
Sierra Oncology assumed with a Buy at H.C. Wainwright
SRRA Sierra Oncology
$17.24 /

+0.24 (+1.41%)

Hot Stocks
Apple Hospitality REIT not issuing 2021 outlook due to Covid uncertainties » 16:20
08/05/21
08/05
16:20
08/05/21
16:20
APLE

Apple Hospitality REIT

$14.86 /

+0.59 (+4.13%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APLE Apple Hospitality REIT
$14.86 /

+0.59 (+4.13%)

APLE Apple Hospitality REIT
$14.86 /

+0.59 (+4.13%)

06/15/21 B. Riley
Apple Hospitality REIT price target raised to $17 from $16 at B. Riley
12/02/20 B. Riley Securities
Apple Hospitality REIT downgraded to Neutral from Buy at B. Riley Securities
12/02/20 B. Riley Securities
Apple Hospitality REIT downgraded at B. Riley Securities
10/05/20 Compass Point
Apple Hospitality REIT initiated with a Buy at Compass Point
APLE Apple Hospitality REIT
$14.86 /

+0.59 (+4.13%)

Syndicate
Intrusion files $100M mixed securities shelf  16:20
08/05/21
08/05
16:20
08/05/21
16:20
INTZ

Intrusion

$4.71 /

+0.47 (+11.08%)

 
ShowHide Related Items >><<
INTZ Intrusion
$4.71 /

+0.47 (+11.08%)

INTZ Intrusion
$4.71 /

+0.47 (+11.08%)

07/21/21 H.C. Wainwright
Intrusion downgraded to Neutral from Buy at H.C. Wainwright
05/05/21 H.C. Wainwright
Intrusion price target lowered to $25 from $35 at H.C. Wainwright
05/05/21 B. Riley
B. Riley downgrades Intrusion on limited visibility into revenue ramp
05/05/21 B. Riley
Intrusion downgraded to Neutral from Buy at B. Riley
INTZ Intrusion
$4.71 /

+0.47 (+11.08%)

  • 09
    Oct
INTZ Intrusion
$4.71 /

+0.47 (+11.08%)

INTZ Intrusion
$4.71 /

+0.47 (+11.08%)

Hot Stocks
Park Hotels & Resorts not providing outlook for FY21 at this time » 16:20
08/05/21
08/05
16:20
08/05/21
16:20
PK

Park Hotels & Resorts

$18.63 /

+1.2 (+6.89%)

Given the continued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PK Park Hotels & Resorts
$18.63 /

+1.2 (+6.89%)

PK Park Hotels & Resorts
$18.63 /

+1.2 (+6.89%)

07/14/21 Deutsche Bank
Park Hotels & Resorts upgraded to Buy from Hold at Deutsche Bank
07/14/21 Deutsche Bank
Park Hotels & Resorts upgraded to Buy from Hold at Deutsche Bank
07/12/21 Evercore ISI
Park Hotels upgraded to Outperform at Evercore ISI after underperformance
07/12/21 Evercore ISI
Park Hotels & Resorts upgraded to Outperform from In Line at Evercore ISI
PK Park Hotels & Resorts
$18.63 /

+1.2 (+6.89%)

Earnings
Quanterix reports Q2 revenue $25.4M, consensus $23.38M » 16:20
08/05/21
08/05
16:20
08/05/21
16:20
QTRX

Quanterix

$56.56 /

+0.96 (+1.73%)

"The past quarter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QTRX Quanterix
$56.56 /

+0.96 (+1.73%)

QTRX Quanterix
$56.56 /

+0.96 (+1.73%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Goldman Sachs
Quanterix initiated with a Sell at Goldman Sachs
05/06/21 SVB Leerink
Quanterix price target lowered to $70 from $85 at SVB Leerink
03/03/21 SVB Leerink
Quanterix price target raised to $85 from $75 at SVB Leerink
QTRX Quanterix
$56.56 /

+0.96 (+1.73%)

  • 04
    Feb
  • 07
    Aug
QTRX Quanterix
$56.56 /

+0.96 (+1.73%)

Earnings
Fox Factory sees FY21 EPS $4.25-$4.45, consensus $4.01 » 16:20
08/05/21
08/05
16:20
08/05/21
16:20
FOXF

Fox Factory

$159.10 /

+3.77 (+2.43%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

06/21/21 Jefferies
Fox Factory assumed with a Buy at Jefferies
05/07/21 Truist
Fox Factory price target raised to $165 from $140 at Truist
04/30/21 Stifel
Fox Factory downgraded to Hold on valuation at Stifel
04/30/21 Stifel
Fox Factory downgraded to Hold from Buy at Stifel
FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

Earnings
Groupon backs FY21 revenue view, updates adjusted EBITDA guidance » 16:20
08/05/21
08/05
16:20
08/05/21
16:20
GRPN

Groupon

$35.58 /

-0.26 (-0.73%)

Groupon said: "For…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRPN Groupon
$35.58 /

-0.26 (-0.73%)

GRPN Groupon
$35.58 /

-0.26 (-0.73%)

06/11/21 Ascendiant
Groupon price target raised to $70 from $42 at Ascendiant
05/10/21 Credit Suisse
Groupon price target raised to $42 from $35 at Credit Suisse
05/10/21 Barclays
Groupon price target raised to $35 from $28 at Barclays
03/03/21 Wedbush
Groupon price target raised to $62 from $29 at Wedbush
GRPN Groupon
$35.58 /

-0.26 (-0.73%)

GRPN Groupon
$35.58 /

-0.26 (-0.73%)

GRPN Groupon
$35.58 /

-0.26 (-0.73%)

Earnings
Park Hotels & Resorts reports Q2 adjusted FFO (16c), consensus (27c) » 16:20
08/05/21
08/05
16:20
08/05/21
16:20
PK

Park Hotels & Resorts

$18.63 /

+1.2 (+6.89%)

Pro-forma RevPAR was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PK Park Hotels & Resorts
$18.63 /

+1.2 (+6.89%)

PK Park Hotels & Resorts
$18.63 /

+1.2 (+6.89%)

07/14/21 Deutsche Bank
Park Hotels & Resorts upgraded to Buy from Hold at Deutsche Bank
07/14/21 Deutsche Bank
Park Hotels & Resorts upgraded to Buy from Hold at Deutsche Bank
07/12/21 Evercore ISI
Park Hotels upgraded to Outperform at Evercore ISI after underperformance
07/12/21 Evercore ISI
Park Hotels & Resorts upgraded to Outperform from In Line at Evercore ISI
PK Park Hotels & Resorts
$18.63 /

+1.2 (+6.89%)

Options
Closing CBOE SPX and VIX Index summary for August 5th » 16:20
08/05/21
08/05
16:20
08/05/21
16:20
VIX

Volatility Index S&P 500 Options

/

+

The CBOE Volatility Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIX Volatility Index S&P 500 Options
/

+

Hot Stocks
Sierra Oncology signs exclusive licensing deal with AstraZeneca for AZD5153 » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
SRRA

Sierra Oncology

$17.24 /

+0.24 (+1.41%)

, AZN

AstraZeneca

$58.41 /

+1.1 (+1.92%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRRA Sierra Oncology
$17.24 /

+0.24 (+1.41%)

AZN AstraZeneca
$58.41 /

+1.1 (+1.92%)

SRRA Sierra Oncology
$17.24 /

+0.24 (+1.41%)

12/11/20 H.C. Wainwright
Sierra Oncology assumed with a Buy at H.C. Wainwright
AZN AstraZeneca
$58.41 /

+1.1 (+1.92%)

08/04/21 SVB Leerink
AstraZeneca price target raised to $69 from $63 at SVB Leerink
07/21/21 Citi
AstraZeneca price target raised to 10,500 GBp from 10,000 GBp at Citi
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
06/17/21 UBS
AstraZeneca price target raised to 9,200 GBp from 8,000 GBp at UBS
SRRA Sierra Oncology
$17.24 /

+0.24 (+1.41%)

AZN AstraZeneca
$58.41 /

+1.1 (+1.92%)

AZN AstraZeneca
$58.41 /

+1.1 (+1.92%)

AZN AstraZeneca
$58.41 /

+1.1 (+1.92%)

AZN AstraZeneca
$58.41 /

+1.1 (+1.92%)

Earnings
Apple Hospitality REIT reports FFO 30c, consensus 20c » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
APLE

Apple Hospitality REIT

$14.86 /

+0.59 (+4.13%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APLE Apple Hospitality REIT
$14.86 /

+0.59 (+4.13%)

APLE Apple Hospitality REIT
$14.86 /

+0.59 (+4.13%)

06/15/21 B. Riley
Apple Hospitality REIT price target raised to $17 from $16 at B. Riley
12/02/20 B. Riley Securities
Apple Hospitality REIT downgraded to Neutral from Buy at B. Riley Securities
12/02/20 B. Riley Securities
Apple Hospitality REIT downgraded at B. Riley Securities
10/05/20 Compass Point
Apple Hospitality REIT initiated with a Buy at Compass Point
APLE Apple Hospitality REIT
$14.86 /

+0.59 (+4.13%)

Earnings
Eiger BioPharmaceuticals reports Q2 EPS (57c), consensus (55c) » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
EIGR

Eiger BioPharmaceuticals

$8.22 /

+0.63 (+8.30%)

Reports Q2 revenue $2.1M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EIGR Eiger BioPharmaceuticals
$8.22 /

+0.63 (+8.30%)

EIGR Eiger BioPharmaceuticals
$8.22 /

+0.63 (+8.30%)

05/11/21 Citi
Eiger BioPharmaceuticals price target raised to $26 from $23 at Citi
12/11/20 BTIG
Gilead investment says Hepatitis Delta opportunity is 'real,' says BTIG
EIGR Eiger BioPharmaceuticals
$8.22 /

+0.63 (+8.30%)

Earnings
Cushman & Wakefield reports Q2 adjusted EPS 50c, consensus 20c » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
CWK

Cushman & Wakefield

$19.28 /

+0.32 (+1.69%)

Reports Q2 revenue $2.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CWK Cushman & Wakefield
$19.28 /

+0.32 (+1.69%)

CWK Cushman & Wakefield
$19.28 /

+0.32 (+1.69%)

07/09/21 JPMorgan
Cushman & Wakefield price target raised to $20 from $17 at JPMorgan
06/14/21 Wolfe Research
Cushman & Wakefield initiated with an Outperform at Wolfe Research
05/17/21 BofA
Cushman & Wakefield downgraded to Underperform from Neutral at BofA
01/25/21
Fly Intel: Top five analyst initiations
CWK Cushman & Wakefield
$19.28 /

+0.32 (+1.69%)

  • 03
    Jun
Earnings
Nabriva Therapeutics reports Q2 EPS (29c), consensus (35c) » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
NBRV

Nabriva Therapeutics

$1.17 /

-0.04 (-3.31%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NBRV Nabriva Therapeutics
$1.17 /

-0.04 (-3.31%)

NBRV Nabriva Therapeutics
$1.17 /

-0.04 (-3.31%)

03/12/21 Northland
Nabriva Therapeutics price target lowered to $6 from $9 at Northland
  • 11
    Dec
NBRV Nabriva Therapeutics
$1.17 /

-0.04 (-3.31%)

NBRV Nabriva Therapeutics
$1.17 /

-0.04 (-3.31%)

Earnings
Fox Factory sees Q3 EPS 95c-$1.15, consensus $1.06 » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
FOXF

Fox Factory

$159.10 /

+3.77 (+2.43%)

Sees Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

06/21/21 Jefferies
Fox Factory assumed with a Buy at Jefferies
05/07/21 Truist
Fox Factory price target raised to $165 from $140 at Truist
04/30/21 Stifel
Fox Factory downgraded to Hold on valuation at Stifel
04/30/21 Stifel
Fox Factory downgraded to Hold from Buy at Stifel
FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

Earnings
Groupon reports Q2 EPS 33c, consensus (3c) » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
GRPN

Groupon

$35.58 /

-0.26 (-0.73%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRPN Groupon
$35.58 /

-0.26 (-0.73%)

GRPN Groupon
$35.58 /

-0.26 (-0.73%)

06/11/21 Ascendiant
Groupon price target raised to $70 from $42 at Ascendiant
05/10/21 Credit Suisse
Groupon price target raised to $42 from $35 at Credit Suisse
05/10/21 Barclays
Groupon price target raised to $35 from $28 at Barclays
03/03/21 Wedbush
Groupon price target raised to $62 from $29 at Wedbush
GRPN Groupon
$35.58 /

-0.26 (-0.73%)

GRPN Groupon
$35.58 /

-0.26 (-0.73%)

GRPN Groupon
$35.58 /

-0.26 (-0.73%)

Earnings
Health Catalyst sees Q3 revenue $59.4M-$62.4M, consensus $58.7M » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
HCAT

Health Catalyst

$56.89 /

+1 (+1.79%)

Sees Adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

05/27/21 Truist
Health Catalyst price target raised to $60 from $55 at Truist
05/07/21 Cantor Fitzgerald
Health Catalyst price target raised to $60 from $52 at Cantor Fitzgerald
05/07/21 Piper Sandler
Health Catalyst price target raised to $57 from $54 at Piper Sandler
04/29/21 JPMorgan
Health Catalyst resumed with an Overweight at JPMorgan
HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

Earnings
Health Catalyst sees FY21 revenue $236.7M-$239.7M, consensus $232.13M » 16:18
08/05/21
08/05
16:18
08/05/21
16:18
HCAT

Health Catalyst

$56.89 /

+1 (+1.79%)

Sees Adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

05/27/21 Truist
Health Catalyst price target raised to $60 from $55 at Truist
05/07/21 Cantor Fitzgerald
Health Catalyst price target raised to $60 from $52 at Cantor Fitzgerald
05/07/21 Piper Sandler
Health Catalyst price target raised to $57 from $54 at Piper Sandler
04/29/21 JPMorgan
Health Catalyst resumed with an Overweight at JPMorgan
HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

Earnings
Brighthouse Financial reports Q2 adjusted EPS $5.32, consensus $2.88 » 16:18
08/05/21
08/05
16:18
08/05/21
16:18
BHF

Brighthouse Financial

$44.08 /

+2.63 (+6.34%)

"Brighthouse…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHF Brighthouse Financial
$44.08 /

+2.63 (+6.34%)

BHF Brighthouse Financial
$44.08 /

+2.63 (+6.34%)

07/08/21 Piper Sandler
Brighthouse Financial price target lowered to $46 from $53 at Piper Sandler
05/12/21 RBC Capital
Brighthouse Financial price target raised to $46 from $39 at RBC Capital
04/12/21 Barclays
Brighthouse Financial price target raised to $46 from $40 at Barclays
04/05/21 JPMorgan
Brighthouse Financial price target raised to $47 from $37 at JPMorgan
BHF Brighthouse Financial
$44.08 /

+2.63 (+6.34%)

Earnings
Zogenix reports Q2 EPS ($1.05), consensus (94c) » 16:18
08/05/21
08/05
16:18
08/05/21
16:18
ZGNX

Zogenix

$16.53 /

+0.36 (+2.23%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZGNX Zogenix
$16.53 /

+0.36 (+2.23%)

ZGNX Zogenix
$16.53 /

+0.36 (+2.23%)

05/07/21 Mizuho
Zogenix shares at 'very attractive entry point,' says Mizuho
04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
ZGNX Zogenix
$16.53 /

+0.36 (+2.23%)

Hot Stocks
Carlisle raises quarterly dividend by 3% to 54c per share » 16:18
08/05/21
08/05
16:18
08/05/21
16:18
CSL

Carlisle

$204.01 /

+0.91 (+0.45%)

The dividend is payable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSL Carlisle
$204.01 /

+0.91 (+0.45%)

CSL Carlisle
$204.01 /

+0.91 (+0.45%)

07/23/21 Oppenheimer
Carlisle price target raised to $230 from $220 at Oppenheimer
07/23/21 Baird
Carlisle price target raised to $230 from $216 at Baird
07/14/21 Oppenheimer
Carlisle price target raised to $220 from $210 at Oppenheimer
06/30/21 Northcoast
Carlisle upgraded to Buy from Neutral at Northcoast
CSL Carlisle
$204.01 /

+0.91 (+0.45%)

Earnings
Fox Factory reports Q2 EPS $1.20, consensus $1.02 » 16:18
08/05/21
08/05
16:18
08/05/21
16:18
FOXF

Fox Factory

$159.10 /

+3.77 (+2.43%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

06/21/21 Jefferies
Fox Factory assumed with a Buy at Jefferies
05/07/21 Truist
Fox Factory price target raised to $165 from $140 at Truist
04/30/21 Stifel
Fox Factory downgraded to Hold on valuation at Stifel
04/30/21 Stifel
Fox Factory downgraded to Hold from Buy at Stifel
FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.